| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Medical Department, Brookhaven National Laboratory,3 Upton, New York 11973
In a comparative study, female ACI and Sprague-Dawley rats were implanted with pellets containing 5 mg diethylstilbestrol (DES) and 15 mg cholesterol for periods ranging from 2 to 214 days. Strain differences in mammary tumorigenesis, plasma prolactin levels, and gross pituitary responses indicated a desirability for examining the cytology of pituitary glands that were fixed during the course of this study and an immunohistochemical evaluation of their prolactin cell responses. Although plasma prolactin levels were elevated in both strains by 2 days after DES pellet implantation, during the first 10 days of treatment there were no significant increases in pituitary weight in both strains. Pituitary glands from experimental animals of both strains killed on Day 10 exhibited enlarged anti-rat prolactin-binding cells. By Day 28, the pituitary glands of DES-treated ACI rats were significantly enlarged, and a hypertrophic and hyperplastic response of their prolactin cells was detected. From Day 56 to the end of the experiment, gross pituitary tumorigenesis was evident in the ACI but not in the Sprague-Dawley rats. At the microscopic level, adenomatous lesions involving prolactin cell hyperplasia were observed in both strains. Sprague-Dawley and ACI rats exhibited multiple centers of marked vascularization predominated by granular acidophilic cells. These centers were more extensive and larger in the pituitaries of the ACI rats. Two types of immunoreactive prolactin cells were observed in lesioned pituitary glands of both strains: polyhedral, strongly reactive cells which were hypertrophic and more numerous in the ACI rats; and smaller, weakly reactive cells which were numerous in the adenomatous areas of the glands in both strains. It was concluded that the lesions in ACI and Sprague-Dawley females represented different quantitative responses of their prolactin cells to DES treatment.
1 Research performed under United States Department of Energy Contract EY-76-C-02-0016, National Cancer Institute Contract Y01-CP-30213, and USPHS Grant 5-T01-Ca-05243.
2 To whom requests for reprints should be addressed.
3 Operated by Associated Universities, Inc., under contract to the United States Department of Energy.
Received 8/18/78. Accepted 11/28/78.
This article has been cited by other articles:
![]() |
T. E. Strecker, T. J. Spady, B. S. Schaffer, K. A. Gould, A. E. Kaufman, F. Shen, M. T. McLaughlin, K. L. Pennington, J. L. Meza, and J. D. Shull Genetic Bases of Estrogen-Induced Pituitary Tumorigenesis: Identification of Genetic Loci Determining Estrogen-Induced Pituitary Growth in Reciprocal Crosses Between the ACI and Copenhagen Rat Strains Genetics, April 1, 2005; 169(4): 2189 - 2197. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pandey, A. Bannout, and D. L. Wendell The Edpm5 locus prevents the 'angiogenic switch' in an estrogen-induced rat pituitary tumor Carcinogenesis, October 1, 2004; 25(10): 1829 - 1838. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. T. Hentges and M. J. Low Ovarian Dependence for Pituitary Tumorigenesis in D2 Dopamine Receptor-Deficient Mice Endocrinology, December 1, 2002; 143(12): 4536 - 4543. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Fitts, R. M. Klein, and C. A. Powers Estrogen and Tamoxifen Interplay with T3 in Male Rats: Pharmacologically Distinct Classes of Estrogen Responses Affecting Growth, Bone, and Lipid Metabolism, and Their Relation to Serum GH and IGF-I Endocrinology, October 1, 2001; 142(10): 4223 - 4235. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Spady, K. L. Pennington, R. D. McComb, and J. D. Shull Genetic Bases of Estrogen-Induced Pituitary Growth in an Intercross between the ACI and Copenhagen Rat Strains: Dominant Mendelian Inheritance of the ACI Phenotype Endocrinology, June 1, 1999; 140(6): 2828 - 2835. [Abstract] [Full Text] |
||||
![]() |
T. J. Spady, D. M. E. Harvell, A. Lemus-Wilson, T. E. Strecker, K. L. Pennington, E. A. Vander Woude, D. F. Birt, R. D. McComb, and J. D. Shull Modulation of Estrogen Action in the Rat Pituitary and Mammary Glands by Dietary Energy Consumption J. Nutr., February 1, 1999; 129(2): 587 - 587. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.A. Clapper, J.L. Snyder, A.J. Roberts, D.L. Hamernik, and G.E. Moss Estradiol Increases Relative Amounts of Insulin-Like Growth Factor Binding Protein (IGFBP)-3 in Serum and Expression of IGFBP-2 in Anterior Pituitaries of Ewes Biol Reprod, July 1, 1998; 59(1): 124 - 130. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |